In other countries
The same active substances on other registers, the same brand first.
- OmlycloBrazil · Celltrion Healthcare Distribuicao de Produtos Farmaceuticos Dos Brasil LtdaSame brand
- OmlycloCanada · 150 MG / 1 ML · Solution · Celltrion INC.Same brand
- OmlycloCanada · 150 MG / 1 ML · Solution · Celltrion INC.Same brand
- OmlycloCanada · 75 MG / 0.5 ML · Solution · Celltrion INC.Same brand
- Omlyclo 150 MG Solucion Inyectable en Jeringa PrecargadaSpain · 150 mg · solución inyectable en jeringa precargada · Celltrion Healthcare Hungary Kft.Same brand
- Omlyclo 150 MG Solucion Inyectable en Pluma PrecargadaSpain · 150 mg · solución inyectable en pluma precargada · Celltrion Healthcare Hungary Kft.Same brand
- Omlyclo 300 MG Solucion Inyectable en Jeringa PrecargadaSpain · 300 mg · solución inyectable · Celltrion Healthcare Hungary Kft.Same brand
- OmlycloEuropean Union · Celltrion Healthcare Hungary Kft.Same brand
- OmlycloItaly · Soluzione iniettabile in penna pre-riempita · Celltrion Healthcare Hungary KFTSame brand
- Omlyclo 150 mg oplossing voor injectie in een voorgevulde penNetherlands · Oplossing voor injectie · Celltrion Healthcare Hungary Kft.Same brand
- Omlyclo 150 mg oplossing voor injectie in een voorgevulde spuitNetherlands · Oplossing voor injectie · Celltrion Healthcare Hungary Kft.Same brand
- Omlyclo 300 mg oplossing voor injectie in een voorgevulde spuitNetherlands · Oplossing voor injectie · Celltrion Healthcare Hungary Kft.Same brand
- Omlyclo® Solution for Injection in Pre-Filled Syringe 150 MG/1MLSingapore · 150 mg/1ml · injection, solution · Celltrion Healthcare Singapore Private LimitedSame brand
- Omlyclo® Solution for Injection in Pre-Filled Syringe 75MG/0.5MLSingapore · 75 mg/0.5ml · injection, solution · Celltrion Healthcare Singapore Private LimitedSame brand
- OmlycloUnited States · 150MG/ML, 300MG/2ML, 75MG/0.5ML · injectable · Celltrion INCSame brand
- XolairBrazil · Novartis Biociencias S.ASame form
- XolairEuropean Union · Novartis Europharm LimitedSame form
- XolairSaudi Arabia · Vetter Pharma-Fertigung, GMBH & Co. KGSame form
- XolairSaudi Arabia · Vetter Pharma-Fertigung, GMBH & Co. KGSame form
- XolairItaly · Soluzione iniettabile · Novartis Europharm LimitedSame substance
- XolairNew Zealand · Inj 150 mg prefilled syringeSame substance
- XolairNew Zealand · Inj 150 mg vialSame substance
- Xolair AUNew Zealand · Inj 150 mg prefilled syringeSame substance
- XOLAIR 150 mgRomania · 150mg · sol inj. · Novartis Europharm LimitedSame substance
- XOLAIR 150mgRomania · 150mg · sol. inj. · Novartis Europharm LTDSame substance
- XOLAIR 75 mgRomania · 75mg · sol inj. · Novartis Europharm LimitedSame substance
- Xolair®Serbia · 75mg/0.5mL · rastvor za injekciju u napunjenom injekcionom špricu · PredstavniŠTvo Novartis Pharma Services INC. Beograd (Novi Beograd)Same substance
- Xolair®Serbia · 75mg/0.5mL · rastvor za injekciju u napunjenom injekcionom špricu · PredstavniŠTvo Novartis Pharma Services INC. Beograd (Novi Beograd)Same substance
- Xolair®Serbia · 75mg/0.5mL · rastvor za injekciju u napunjenom injekcionom penu · PredstavniŠTvo Novartis Pharma Services INC. Beograd (Novi Beograd)Same substance
- XOLAIR 150MG Powder for injectionSaudi Arabia · NovartisSame substance
- Xolair Solution for Injection in Pre-Filled Pen 150MG/1.0MLSingapore · 150.00 mg/1.0 mL · injection, solution · Novartis (Singapore) Pte LTDSame substance
- XolairUnited States · 150MG/ML, 300MG/2ML, 75MG/0.5ML · syringe · GenentechSame substance
- XolairUnited States · 150MG/VIAL · vial · GenentechSame substance
Sources and licences
Compiled by Prognia from the public register below; the register’s text is the official one.
HALMED — Agencija za lijekove i medicinske proizvode RH
HALMED, Baza lijekova, source export 08.10.2026., acquired 2026-10-08; factual structured adaptation; Otvorena dozvola RH, NN 67/2017.
Licence: Otvorena dozvola RH NN 67/2017 · Added 8 Oct 2026
Report an error or request removalCorrections from the holder or the register are welcome.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Active substance
- Omalizumab
- Register
- Croatia (HALMED)
- Status
- Marketed
- Status in the register
- stavljeno u promet; nema nestašice
- Registration
- 17297
- ATC code
- R03DX05
- Group
- Respiratory system
- Procedure
- EU centralised
- Supply
- na recept; u ljekarni